This company has been marked as potentially delisted and may not be actively trading. Chinook Therapeutics (KDNY) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock KDNY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Chinook, United States - Weather Forecasts | Maps | News - Yahoo WeatherMay 21, 2024 | yahoo.comThree Finalists Announced for the 2024 Bloom Burton AwardApril 21, 2024 | finance.yahoo.comChinook ElementaryNovember 1, 2023 | usnews.comChinook Therapeutics, Inc. (NASDAQ:KDNY) is Altium Capital Management LP's 5th Largest PositionSeptember 12, 2023 | marketbeat.comChinook Therapeutics, Inc. (NASDAQ:KDNY) Receives Consensus Recommendation of "Hold" from AnalystsSeptember 6, 2023 | marketbeat.comCitigroup Inc. Boosts Holdings in Chinook Therapeutics, Inc. (NASDAQ:KDNY)September 4, 2023 | marketbeat.comChinook Therapeutics, Inc. (NASDAQ:KDNY) Shares Sold by C M Bidwell & Associates Ltd.September 1, 2023 | marketbeat.comCHI Advisors LLC Makes New Investment in Chinook Therapeutics, Inc. (NASDAQ:KDNY)August 25, 2023 | marketbeat.comChinook Therapeutics, Inc. (NASDAQ:KDNY) Shares Sold by Connor Clark & Lunn Investment Management Ltd.August 20, 2023 | marketbeat.comBarclays PLC Lowers Stake in Chinook Therapeutics, Inc. (NASDAQ:KDNY)August 18, 2023 | marketbeat.comChinook Therapeutics (Nasdaq:KDNY) HeadlineTrading was temporarily halted for "KDNY" at 07:08 PM with a stated reason of "News pending."...August 11, 2023 | marketbeat.comQ3 2023 Earnings Forecast for Chinook Therapeutics, Inc. Issued By Wedbush (NASDAQ:KDNY)August 10, 2023 | marketbeat.comWedbush Downgrades Chinook Therapeutics (KDNY)August 8, 2023 | msn.comChinook Therapeutics, Inc. (KDNY)August 2, 2023 | uk.finance.yahoo.comExpert Ratings for Chinook TherapeuticsAugust 1, 2023 | markets.businessinsider.comWells Fargo Downgrades Chinook Therapeutics (KDNY)August 1, 2023 | msn.comChinook Therapeutics (NASDAQ:KDNY) Downgraded by Wells Fargo & Company to Equal WeightAugust 1, 2023 | marketbeat.comChinook Therapeutics, Inc. (NASDAQ:KDNY) Shares Sold by Baillie Gifford & Co.July 28, 2023 | marketbeat.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KDNY, NETI, TALS, QUOTJuly 25, 2023 | markets.businessinsider.comSG Americas Securities LLC Increases Position in Chinook Therapeutics, Inc. (NASDAQ:KDNY)July 20, 2023 | marketbeat.comChinook Therapeutics, Inc. (NASDAQ:KDNY) Receives Average Rating of "Hold" from AnalystsJuly 18, 2023 | marketbeat.comChinook Therapeutics (NASDAQ: KDNY)July 16, 2023 | fool.comChinook Therapeutics, Inc. (NASDAQ:KDNY) Position Increased by Hennion & Walsh Asset Management Inc.July 7, 2023 | marketbeat.comShort Interest in Chinook Therapeutics, Inc. (NASDAQ:KDNY) Drops By 56.4%June 30, 2023 | marketbeat.comAssenagon Asset Management S.A. Purchases 483,220 Shares of Chinook Therapeutics, Inc. (NASDAQ:KDNY)June 29, 2023 | marketbeat.comChinook Therapeutics, Inc. (NASDAQ:KDNY) Given Average Recommendation of "Hold" by AnalystsJune 23, 2023 | marketbeat.comChinook: Surprising Acquisition By Novartis, Deal Should Go ThroughJune 21, 2023 | seekingalpha.comVictory Capital Management Inc. Grows Holdings in Chinook Therapeutics, Inc. (NASDAQ:KDNY)June 21, 2023 | marketbeat.comChinook Therapeutics Presents Data from CHK-336 Phase 1 Trial in Healthy Volunteers and New Insights into the Role of Failed Repair in Chronic Kidney Disease at the 60th European Renal Association (ERA) CongressJune 17, 2023 | finance.yahoo.comMoore Kuehn Encourages NETI, SURF, KDNY, and NEX Investors to Contact Law FirmJune 16, 2023 | benzinga.comChinook Therapeutics, Inc. (NASDAQ:KDNY) Shares Sold by HealthCor Management L.P.June 15, 2023 | marketbeat.comCHINOOK THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chinook ...June 13, 2023 | businesswire.comKDNY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Chinook Therapeutics, Inc. Is Fair to ShareholdersJune 13, 2023 | barrons.comNovartis Stock Screams Value After Chinook Therapeutics Buyout (KDNY)Following a buyout of Chinook Therapeutics, Novartis slipped less than 1%. This speaks to the growth potential of Chinook and ongoing value of Novartis stock.June 13, 2023 | marketbeat.comNovartis buys Chinook for $3.5 bln in race to treat rare kidney diseaseJune 12, 2023 | reuters.comWhy Are Chinook Therapeutics Shares Trading Higher TodayJune 12, 2023 | markets.businessinsider.comWhat 6 Analyst Ratings Have To Say About Chinook TherapeuticsJune 12, 2023 | markets.businessinsider.comChinook Therapeutics to Present Updated Data from Zigakibart (BION-1301) Phase 1/2 Trial in Patients with IgA Nephropathy (IgAN) at the 60th European Renal Association (ERA) CongressJune 12, 2023 | finance.yahoo.comNovartis Buys Chinook: M&A To Drive Future GrowthJune 12, 2023 | seekingalpha.comChinook Therapeutics (NASDAQ:KDNY) Downgraded to Neutral at GuggenheimJune 12, 2023 | marketbeat.comWhy Is Chinook Therapeutics (KDNY) Stock Up 58% Today?June 12, 2023 | investorplace.comGyon Technologies Capital Management LP Makes New $496,000 Investment in Chinook Therapeutics, Inc. (NASDAQ:KDNY)June 9, 2023 | marketbeat.comChinook Shareholder Action ReminderJune 8, 2023 | markets.businessinsider.comExodusPoint Capital Management LP Sells 41,701 Shares of Chinook Therapeutics, Inc. (NASDAQ:KDNY)June 7, 2023 | marketbeat.comPrincipal Financial Group Inc. Grows Stock Holdings in Chinook Therapeutics, Inc. (NASDAQ:KDNY)June 5, 2023 | marketbeat.comChinook Therapeutics, Inc. (NASDAQ:KDNY) Shares Acquired by Mirae Asset Global Investments Co. Ltd.June 2, 2023 | marketbeat.comChinook Therapeutics, Inc. (NASDAQ:KDNY) Given Average Recommendation of "Buy" by BrokeragesMay 29, 2023 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Sells 51,468 Shares of Chinook Therapeutics, Inc. (NASDAQ:KDNY)May 26, 2023 | marketbeat.comSwiss National Bank Acquires 5,200 Shares of Chinook Therapeutics, Inc. (NASDAQ:KDNY)May 25, 2023 | marketbeat.comFY2023 EPS Estimates for Chinook Therapeutics, Inc. (NASDAQ:KDNY) Reduced by AnalystMay 24, 2023 | marketbeat.com Get Chinook Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KDNY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KDNY Media Mentions By Week KDNY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KDNY News Sentiment▼0.670.93▲Average Medical News Sentiment KDNY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KDNY Articles This Week▼00▲KDNY Articles Average Week Get the Latest News and Ratings for KDNY and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Chinook Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies HYPD News Today PHXM News Today ADIL News Today SXTPW News Today DRTSW News Today BCTXW News Today ENGNW News Today FBIOP News Today GOVXW News Today JSPRW News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KDNY) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chinook Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Chinook Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KDNY Stock Alerts